- Home
- USNA vs ALDX Comparison
USNA vs ALDX Comparison
Compare USNA & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- ALDX
- Stock Information
- Founded
- USNA 1992
- ALDX 2004
- Country
- USNA United States
- ALDX United States
- Employees
- USNA N/A
- ALDX N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- USNA Health Care
- ALDX Health Care
- Exchange
- USNA Nasdaq
- ALDX Nasdaq
- Market Cap
- USNA 461.9M
- ALDX 133.7M
- IPO Year
- USNA 1996
- ALDX 2014
- Fundamental
- Price
- USNA $29.43
- ALDX $2.24
- Analyst Decision
- USNA Hold
- ALDX Strong Buy
- Analyst Count
- USNA 1
- ALDX 2
- Target Price
- USNA $36.00
- ALDX $9.50
- AVG Volume (30 Days)
- USNA 234.9K
- ALDX 1.5M
- Earning Date
- USNA 04-22-2025
- ALDX 05-20-2025
- Dividend Yield
- USNA N/A
- ALDX N/A
- EPS Growth
- USNA N/A
- ALDX N/A
- EPS
- USNA 1.82
- ALDX N/A
- Revenue
- USNA $876,242,000.00
- ALDX N/A
- Revenue This Year
- USNA $13.04
- ALDX N/A
- Revenue Next Year
- USNA $7.36
- ALDX N/A
- P/E Ratio
- USNA $16.05
- ALDX N/A
- Revenue Growth
- USNA N/A
- ALDX N/A
- 52 Week Low
- USNA $23.10
- ALDX $1.14
- 52 Week High
- USNA $49.78
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- USNA 64.69
- ALDX 36.53
- Support Level
- USNA $27.82
- ALDX $1.90
- Resistance Level
- USNA $29.84
- ALDX $2.89
- Average True Range (ATR)
- USNA 1.10
- ALDX 0.22
- MACD
- USNA 0.44
- ALDX 0.09
- Stochastic Oscillator
- USNA 95.29
- ALDX 33.46
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.